Lantern Laboratory is an early-stage medtech startup developing a novel device/platform utilizing EEG biomarkers to specifically guide pharmacological decisions in the OR and ICU. The technology is based on research in neuroscience, anesthesia, and engineering being done at Columbia University and through collaboration with Columbia Technology Ventures. These advancements in brain monitoring will result in faster, safer awakenings from anesthesia, less postoperative neurocognitive dysfunction, and a reduction in the lifetime risk of dementia in those undergoing surgery or ICU stay.